BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 27924735)

  • 21. Pharmacists' role in handling problems with prescriptions for antithrombotic medication in Belgian community pharmacies.
    Desmaele S; De Wulf I; Dupont AG; Steurbaut S
    Int J Clin Pharm; 2015 Aug; 37(4):656-68. PubMed ID: 25822042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survey of drug-related problems identified by community pharmacies.
    Hämmerlein A; Griese N; Schulz M
    Ann Pharmacother; 2007 Nov; 41(11):1825-32. PubMed ID: 17925500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug related problems identified by European community pharmacists in patients discharged from hospital.
    Paulino EI; Bouvy ML; Gastelurrutia MA; Guerreiro M; Buurma H;
    Pharm World Sci; 2004 Dec; 26(6):353-60. PubMed ID: 15683106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Large scale implementation of clinical medication reviews in Dutch community pharmacies: drug-related problems and interventions.
    Kempen TGH; van de Steeg-van Gompel CH; Hoogland P; Liu Y; Bouvy ML
    Int J Clin Pharm; 2014 Jun; 36(3):630-5. PubMed ID: 24736895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizing the pharmacotherapy of vascular surgery patients by medication reconciliation.
    Hohn N; Langer S; Kalder J; Jacobs MJ; Marx G; Eisert A
    J Cardiovasc Surg (Torino); 2014 Apr; 55(2 Suppl 1):175-81. PubMed ID: 24796911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of interaction risks of patients with polypharmacy and the pharmacist interventions performed to solve them-A multicenter descriptive study according to medication reviews in Hungarian community pharmacies.
    Szilvay A; Somogyi O; Dobszay A; Meskó A; Zelkó R; Hankó B
    PLoS One; 2021; 16(6):e0253645. PubMed ID: 34157039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DREAMeR: Drug use Reconsidered in the Elderly using goal Attainment scales during Medication Review; study protocol of a randomised controlled trial.
    Verdoorn S; Kwint HF; Blom J; Gussekloo J; Bouvy ML
    BMC Geriatr; 2018 Aug; 18(1):190. PubMed ID: 30143003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medication review in German community pharmacies - Post-hoc analysis of documented drug-related problems and subsequent interventions in the ATHINA-project.
    Seidling HM; Send AFJ; Bittmann J; Renner K; Dewald B; Lange D; Bruckner T; Haefeli WE
    Res Social Adm Pharm; 2017 Nov; 13(6):1127-1134. PubMed ID: 27816566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of community pharmacists in providing clinical medication reviews.
    Laaksonen R; Duggan C; Bates I
    Ann Pharmacother; 2010; 44(7-8):1181-90. PubMed ID: 20571102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of medication review on drug-related problems in patients using automated drug-dispensing systems: a pragmatic randomized controlled study.
    Kwint HF; Faber A; Gussekloo J; Bouvy ML
    Drugs Aging; 2011 Apr; 28(4):305-14. PubMed ID: 21428465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Community pharmacists' evaluation of potentially inappropriate prescribing in older community-dwelling patients with polypharmacy: observational research based on the GheOP³S tool.
    Tommelein E; Mehuys E; Van Tongelen I; Petrovic M; Somers A; Colin P; Demarche S; Van Hees T; Christiaens T; Boussery K
    J Public Health (Oxf); 2017 Sep; 39(3):583-592. PubMed ID: 27698269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studying the impact of a medication use evaluation by the community pharmacist (Simenon): Drug-related problems and associated variables.
    Wuyts J; Maesschalck J; De Wulf I; Lelubre M; Foubert K; De Vriese C; Boussery K; Goderis G; De Lepeleire J; Foulon V
    Res Social Adm Pharm; 2020 Aug; 16(8):1100-1110. PubMed ID: 31759887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of an enhanced pharmacy discharge service on prescribing appropriateness criteria: a randomised controlled trial.
    Basger BJ; Moles RJ; Chen TF
    Int J Clin Pharm; 2015 Dec; 37(6):1194-205. PubMed ID: 26297239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of goal attainment scaling during clinical medication review in older persons with polypharmacy.
    Verdoorn S; Blom J; Vogelzang T; Kwint HF; Gussekloo J; Bouvy ML
    Res Social Adm Pharm; 2019 Oct; 15(10):1259-1265. PubMed ID: 30425008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in medicine prescription following a medication review in older high-risk patients with polypharmacy.
    Hurmuz MZM; Janus SIM; van Manen JG
    Int J Clin Pharm; 2018 Apr; 40(2):480-487. PubMed ID: 29453677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a clinical medication review focused on personal goals, quality of life, and health problems in older persons with polypharmacy: A randomised controlled trial (DREAMeR-study).
    Verdoorn S; Kwint HF; Blom JW; Gussekloo J; Bouvy ML
    PLoS Med; 2019 May; 16(5):e1002798. PubMed ID: 31067214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug related problems identified by clinical pharmacist at the Internal Medicine Ward in Turkey.
    Abunahlah N; Elawaisi A; Velibeyoglu FM; Sancar M
    Int J Clin Pharm; 2018 Apr; 40(2):360-367. PubMed ID: 29380236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive medication reviews for elderly patients: findings and recommendations to physicians.
    Leikola SN; Virolainen J; Tuomainen L; Tuominen RK; Airaksinen MS
    J Am Pharm Assoc (2003); 2012; 52(5):630-3. PubMed ID: 23023843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The status of the performance of medication reviews in German community pharmacies and assessment of the practical performance.
    Greißing C; Kössler K; Freyer J; Hüter L; Buchal P; Schiek S; Bertsche T
    Int J Clin Pharm; 2016 Dec; 38(6):1425-1435. PubMed ID: 27783313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of medication review and cognitive behaviour treatment by community pharmacists of patients discharged from the hospital on drug related problems and compliance: design of a randomized controlled trial.
    Ahmad A; Hugtenburg J; Welschen LM; Dekker JM; Nijpels G
    BMC Public Health; 2010 Mar; 10():133. PubMed ID: 20230611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.